Pentraxin 3 is an adipose tissue‐related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss

Cancer cachexia, a paraneoplastic syndrome characterized by ongoing skeletal muscle mass loss, is accompanied by adipose tissue loss and strongly affects chemotherapy endurance. Our aim was to detect a serum marker reflecting pancreatic cancer cachexia and predicting subsequent loss of muscle mass a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Katsuhiko, Hikita, Hayato, Shigekawa, Minoru, Kato, Seiya, Sasaki, Yoichi, Shinkai, Kazuma, Fukuoka, Makoto, Kudo, Shinnosuke, Sato, Yu, Fukumoto, Kenji, Shirai, Kumiko, Myojin, Yuta, Sakane, Sadatsugu, Murai, Kazuhiro, Yoshioka, Teppei, Nishio, Akira, Kodama, Takahiro, Sakamori, Ryotaro, Tatsumi, Tomohide, Takehara, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746057/
https://www.ncbi.nlm.nih.gov/pubmed/36074525
http://dx.doi.org/10.1111/cas.15569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746057/
https://www.ncbi.nlm.nih.gov/pubmed/36074525
http://dx.doi.org/10.1111/cas.15569

Ejemplares similares